University of Miami's 2nd Biennial Miami Leukemia Symposium

 

University of Miami's 2nd Biennial Miami Leukemia Symposium
Avatar

2020 Update on Combination Therapies in R/R CLL: Venetoclax +R, Venetoclax + BTKi, Venetoclax + PI3Ki & BTKi + PI3Ki

By University of Miami's 2nd Biennial Miami Leukemia Symposium FEATURING Matthew Davids
By University of Miami's 2nd Biennial Miami Leukemia Symposium FEATURING Matthew Davids
56 views
May 14, 2020
Comments 0
Login to view comments. Click here to Login

Featured Video

16:51
Incyte

Effects of PV Treatment on White Blood Cell Count and Thrombotic Risk

Feat. C. Harrison

Featured Video

07:44
Incyte

Optimizing the Management of Patients with Polycythemia Vera (PV)

Feat. P. Bose, R. Rampal
CLL Therapy in 2019
13:16

Advances in the CLL Frontline Therapy: BTK Inhibitors vs. Chemoimmun…

University of Miami's 2nd Biennial Miami Leukemia Symposium

J. Woyach

154 views
07:09

The Big Question in CLL Frontline Therapy: How to Choose Between Ibr…

University of Miami's 2nd Biennial Miami Leukemia Symposium

J. Woyach

282 views
24:51

2020 Update on Combination Therapies in R/R CLL: Venetoclax +R, Vene…

University of Miami's 2nd Biennial Miami Leukemia Symposium

M. Davids

56 views